Table 2.
Preoperative evaluation and treatment strategies for patients.
| Case | Sex | Age | Clinical manifestation | Disease location | TNMS | Treatments | Margins | Follow-up (M) | Outcome |
|---|---|---|---|---|---|---|---|---|---|
| 1 | M | 43 | HL, AF, T, Otorrhea | ME | T1N0M0S0a | CWU TM | Nonec | 148 | NED |
| 2 | F | 44 | T | ME | T1N0M0S0 | CWU TM | Negative | 49 | NED |
| 3b | F | 30 | T, AF | ME | T1N0M0S0a | Tympanotomy & lesion excision | Negative | 81 | Recurrent |
| 4 | M | 40 | HL, AF | EAC | T2N0M0S0 | LTBR & superficial parotidectomy | Negative | 45 | NED |
| 5 | M | 62 | HL, AF, T, Otorrhea | ME & EAC | T2N0M0S0 | LTBR | Negative | 21 | NED |
| 6 | M | 44 | HL, AF | ME & EAC | T2N0M0S0 | LTBR | Negative | 8 | NED |
a
Postoperative stage.
b
Case 3 with local recurrence 38 months postoperative, and underwent second surgery, CWU mastoidectomy and type I tympanoplasty with an intact ossicles. 02/10/2015 recurrent, Reddish lesion EAC CWU + Tympanoplasty.
c
Case 1 was misdiagnosed patients without margins report.
HL, Hearing Loss; AF, Aural Fullness; T, Tinnitus; ME, Middle Ear; EAC, External Auditory Canal; CWU, Canal Wall-Up; TM, Tympanomastoidectomy; LTBR, Lateral Temporal Bone Resection; NED, No Evidence of Disease.